Literature DB >> 19692250

Design, synthesis and evaluation of flavonoid derivatives as potent AChE inhibitors.

Rong Sheng1, Xiao Lin, Jing Zhang, Kim Sun Chol, Wenhai Huang, Bo Yang, Qiaojun He, Yongzhou Hu.   

Abstract

A new series of flavonoid derivatives have been designed, synthesized and evaluated as potent AChE inhibitors. Most of them showed more potent inhibitory activities to AChE than rivastigmine. The most potent inhibitor isoflavone derivative 10d inhibit AChE with a IC(50) of 4 nM and showed high BChE/AChE inhibition ratio (4575-fold), superior to donepezil (IC(50)=12 nM, 389-fold). Molecular docking studies were also performed to explore the detailed interaction with AChE.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19692250     DOI: 10.1016/j.bmc.2009.07.072

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  11 in total

Review 1.  Natural products as a source of Alzheimer's drug leads.

Authors:  Philip Williams; Analia Sorribas; Melanie-Jayne R Howes
Journal:  Nat Prod Rep       Date:  2010-11-12       Impact factor: 13.423

Review 2.  Bioactive Compounds and Their Derivatives: An Insight into Prospective Phytotherapeutic Approach against Alzheimer's Disease.

Authors:  Fahadul Islam; Jannatul Fardous Khadija; Md Harun-Or-Rashid; Md Saidur Rahaman; Mohamed H Nafady; Md Rezaul Islam; Aklima Akter; Talha Bin Emran; Polrat Wilairatana; Mohammad S Mubarak
Journal:  Oxid Med Cell Longev       Date:  2022-04-11       Impact factor: 7.310

Review 3.  Elucidating Critical Proteinopathic Mechanisms and Potential Drug Targets in Neurodegeneration.

Authors:  Khalid Bashir Dar; Aashiq Hussain Bhat; Shajrul Amin; Bilal Ahmad Reshi; Mohammad Afzal Zargar; Akbar Masood; Showkat Ahmad Ganie
Journal:  Cell Mol Neurobiol       Date:  2019-10-04       Impact factor: 5.046

4.  The flavonoid derivative 2-(4' Benzyloxyphenyl)-3-hydroxy-chromen-4-one protects against Aβ42-induced neurodegeneration in transgenic Drosophila: insights from in silico and in vivo studies.

Authors:  Sandeep Kumar Singh; Ruchi Gaur; Akhil Kumar; Roshan Fatima; Lallan Mishra; Saripella Srikrishna
Journal:  Neurotox Res       Date:  2014-04-05       Impact factor: 3.911

5.  Synthesis and evaluation of flavanones as anticancer agents.

Authors:  Y Murti; P Mishra
Journal:  Indian J Pharm Sci       Date:  2014-03       Impact factor: 0.975

Review 6.  Flavonoids: an overview.

Authors:  A N Panche; A D Diwan; S R Chandra
Journal:  J Nutr Sci       Date:  2016-12-29

7.  5,6-Dimethoxybenzofuran-3-one derivatives: a novel series of dual Acetylcholinesterase/Butyrylcholinesterase inhibitors bearing benzyl pyridinium moiety.

Authors:  Hamid Nadri; Morteza Pirali-Hamedani; Alireza Moradi; Amirhossein Sakhteman; Alireza Vahidi; Vahid Sheibani; Ali Asadipour; Nouraddin Hosseinzadeh; Mohammad Abdollahi; Abbas Shafiee; Alireza Foroumadi
Journal:  Daru       Date:  2013-02-27       Impact factor: 3.117

8.  Development of dual inhibitors against Alzheimer's disease using fragment-based QSAR and molecular docking.

Authors:  Manisha Goyal; Jaspreet Kaur Dhanjal; Sukriti Goyal; Chetna Tyagi; Rabia Hamid; Abhinav Grover
Journal:  Biomed Res Int       Date:  2014-06-12       Impact factor: 3.411

Review 9.  Current Therapeutic Molecules and Targets in Neurodegenerative Diseases Based on in silico Drug Design.

Authors:  Sheikh Arslan Sehgal; Mirza A Hammad; Rana Adnan Tahir; Hafiza Nisha Akram; Faheem Ahmad
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

10.  Synthesis, Biological Evaluation and Molecular Modelling of 2'-Hydroxychalcones as Acetylcholinesterase Inhibitors.

Authors:  Sri Devi Sukumaran; Chin Fei Chee; Geetha Viswanathan; Michael J C Buckle; Rozana Othman; Noorsaadah Abd Rahman; Lip Yong Chung
Journal:  Molecules       Date:  2016-07-22       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.